AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06396715 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial direct current stimulation
Description: tDCS is a type of non-invasive brain stimulation that in a standard paradigm, low intensity current (1-2 mA) is applied continuously through a battery connected to two 20 to 35 cm2 surface electrodes located on the scalp: an anode and a cathode. In the interhemispheric competition model, tDCS can serve as a means to increase ipsilesional cortical excitability through anodal stimulation, to decrease contralesional cortical excitability through cathodal stimulation, or to do both through a montage of bi-hemispheric electrodes.
Study NCT06396715 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation
Description: tDCS is a type of non-invasive brain stimulation that in a standard paradigm, low intensity current (1-2 mA) is applied continuously through a battery connected to two 20 to 35 cm2 surface electrodes located on the scalp: an anode and a cathode. In the interhemispheric competition model, tDCS can serve as a means to increase ipsilesional cortical excitability through anodal stimulation, to decrease contralesional cortical excitability through cathodal stimulation, or to do both through a montage of bi-hemispheric electrodes.
Study NCT06290713 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tadalafil
Description: Patients will be given either the intervention medication or a placebo (double-blinded, randomized trial) and will be asked to take the medication every day for 6 months in conjunction with weekly exercise sessions.
Study NCT06290713 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will be given either the intervention medication or a placebo (double-blinded, randomized trial) and will be asked to take the medication every day for 6 months in conjunction with weekly exercise sessions.
Study NCT06290713 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Exercise Training
Description: The home-based cycling exercise training program is designed to improve muscle strength and endurance. Participants will engage in individualized exercise sessions up to four times per week, lasting up to 40 minutes each. Live video and heart rate monitoring will ensure proper exercise performance and allow for adjustments to the program throughout the study. The participants will receive the exercise equipment for use at home.
Study NCT06290713 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Training
Description: The home-based cycling exercise training program is designed to improve muscle strength and endurance. Participants will engage in individualized exercise sessions up to four times per week, lasting up to 40 minutes each. Live video and heart rate monitoring will ensure proper exercise performance and allow for adjustments to the program throughout the study. The participants will receive the exercise equipment for use at home.
Study NCT06013956 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neurostimulation
Description: Electrical stimulation delivered via deep brain stimulation electrodes based on measurements of brain activity.
Study NCT06013956 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carbidopa 25/Levodopa 100Mg Tab
Description: Anti-parkinsonian medication.
Study NCT04104919 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brivoligide Injection 660 mg/6 mL
Description: Single preoperative intrathecal injection
Study NCT04104919 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo 6 mL
Description: Single preoperative intrathecal injection
Study NCT05630651 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: ZS801
Description: A novel, bioengineered adeno-associated viral (AAV) vector carrying human factor IX variant. The dose level is 5.0×10\^12vg/kg.
Study NCT04698135 — intervention group
Intervention type: OTHER
Intervention: Biological samples collection
Description: Collection of faeces, coproculture examination, urine, saliva, PBMC and blood for biobanking, to evaluate the proteomic, metascriptomic, metabolomic, metagenomic, and metagenetic profile, and to perform routine screening. Analysis for the identification, quantification and characterization of health-promoting bacteria
Study NCT04698135 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Anamnestic questionnaire, 3-day food questionnaire, Food Frequency Questionnaire
Study NCT04698135 — intervention group
Intervention type: OTHER
Intervention: Medical/laboratory examinations
Description: Blood pressure measurement, abdominal and thoracic physical examination, body composition through bioimpedance analysis and metabolic, cardiovascular and respiratory variables; OGTT 75gr for blood glucose and insulin at times 0, 30, 60, 90 and 120', and a nocturnal oximetry and subsequently, if necessary, overnight polysomnography for the diagnosis of obstructive sleep
Study NCT05961176 — intervention group
Intervention type: DEVICE
Intervention: Skiin pediatric band and Skiin biometric pod
Description: Infants that meet the inclusion criteria will be equipped with a Skiin pediatric band appropriate for their chest size. Heart rate, respiratory rate, temperature, and electrocardiogram will be monitored from 2 to 12 hours through the Skiin pediatric band and a standard of care device (Phillips Intellivue MX750) commonly used in the CCCU at SickKids.
Study NCT05748184 — intervention group
Intervention type: DEVICE
Intervention: PACS viewer prototype
Description: A PACS system mimicking the clinical PACS system used in LUMC.
Study NCT05748184 — intervention group
Intervention type: DEVICE
Intervention: Optimized ULDCT viewer prototype version(s)
Description: The ULDCT viewer prototype is a non-medical unreleased device that will be used by study participants on de-identified image cases in a research setting. The Prototype integrates new tools to speed up the diagnostic interpretation process of radiological images. Optimized version(s) of previous version.
Study NCT06430931 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Minimal invasive abdominal prolapse surgery using Polypropylene mesh
Description: All procedures will be performed with robotic assistance of the da Vinci Si-HD (intuitive Surgical, Inc, Sunnyvale, CA).
Study NCT06430931 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Minimal invasive abdominal prolapse surgery using OviTex 1S permanent mesh
Description: All procedures will be performed with robotic assistance of the da Vinci Si-HD (intuitive Surgical, Inc, Sunnyvale, CA).
Study NCT05443178 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivaquine ® (Chloroquine)
Description: dose escalation and extension trial
Study NCT04154085 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Psychotherapy
Description: Group psychotherapy
Study NCT05870163 — intervention group
Intervention type: DEVICE
Intervention: RefluxStop implantation
Description: Standard surgical technique for implantation RefluxStop, as described in the Itructions for Use
Study NCT05870163 — intervention group
Intervention type: PROCEDURE
Intervention: Nissen fundoplication
Description: Standard of care Nissen fundoplication surgery
Study NCT05939583 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Shock Wave Therapy
Description: Receiving Shock wave therapy + US, TENS, IR and exercises.
Study NCT05939583 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: US, TENS, IR and exercises.
Description: Receiving US, TENS, IR and exercises only.
Study NCT06235684 — intervention group
Intervention type: OTHER
Intervention: Either newly diagnosed with a RD requiring initiation of therapy OR treatment change at the time of inclusion
Description: During the first year, data related to demographics, lifestyle, laboratory and physical examinations will be collected at baseline, at month 3, at month 12 and in case of unscheduled visit. Questionnaires and standardised voice collection will be collected (optionally) at different time points using the Colive web app. Physical activity and sleep quality will be optionally monitored via a smartwatch that will be provided to interested participants. Biological sample(s) and imaging data will be collected at different time points (baseline; 3 months; 12 months; unscheduled visit). A long-term follow-up (starting from month 12 and up to 4 years after month 12) is foreseen in this study. During the long-term follow-up medical data are collected on a yearly basis, and questionnaires are collected every 6 months.
Study NCT05290441 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: None involvement
Description: No EGFR involvement
Study NCT05568030 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness
Description: One session of a 20 minute mindfulness recording, based on standardised script, focused on stress management.
Study NCT05568030 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psycho-education
Description: One session of a 20 minute recording, based on standardised script, focused on psychophysiological stress response description.
Study NCT05945771 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Grape seed extract
Description: Acute effect of dietary supplementation with GSE on hemodynamic responses during static exercise and muscle metaboreflex and during cycling exercise.
Study NCT05945771 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Grape seed extract
Description: Acute effect of dietary supplementation with GSE on hemodynamic responses during static exercise and muscle metaboreflex and during cycling exercise.
Study NCT05223062 — intervention group
Intervention type: OTHER
Intervention: Disease activity in psoriatic arthritis (DAPSA)
Description: DAPSA includes a 68/66 joint count summed with a patient global, patient pain score, and C- reactive protein level. The DAPSA provides a continuous score of arthritis activity and has validated cut points for remission (\< 4) and low disease activity (\< 14).
Study NCT05223062 — intervention group
Intervention type: OTHER
Intervention: Compliance-Questionnaire-Rheumatology (CQR)
Description: The CQR is a self-administered questionnaire that was developed with the aim of correctly identifying patients that were classified as low adherers (taking \<80% of their medication correctly). The four point Likert answering scale ranges from; Definitely don't agree (scored 1) to Definitely agree (scored 4) with lower scores indicating lower levels of adherence. Total score is between 0 and 100.
Study NCT05223062 — intervention group
Intervention type: OTHER
Intervention: The Brief Illness Perception Questionnaire (BIPQ)
Description: The Brief Illness Perception Questionnaire (BIPQ) is a questionnaire that assesses a number of beliefs about illness which are thought to be related to coping and help-seeking behavior. Each item is scored between 0 and 10. Maximum total score is 80. Higher scores represents that the patient has a concerned perception of illness.
Study NCT05223062 — intervention group
Intervention type: OTHER
Intervention: The Beliefs About Medicines Questionnaire (BMQ)
Description: The Beliefs About Medicines Questionnaire (BMQ) is a tool for evaluating people's beliefs about medicines. The BMQ comprises two sections: the BMQ-Specific which assesses representations of medication prescribed for personal use and the BMQ-General which assesses beliefs about medicines in general. It has a total of 18 questions scored with a 5-point Likert scale. Higher scores represent more powerful beliefs.
Study NCT05223062 — intervention group
Intervention type: OTHER
Intervention: Hospital Anxiety and Depression Scale (HADS)
Description: Hospital Anxiety and Depression Scale (HADS) determines the levels of anxiety and depression that a person is experiencing. The HADS is a fourteen item scale that generates: Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression.
Study NCT05223062 — intervention group
Intervention type: OTHER
Intervention: The Psoriatic Arthritis Quality of Life (PsAQoL)
Description: The Psoriatic Arthritis Quality of Life (PsAQoL) measure is a disease specific patient-reported outcome measure which measures the effect that psoriatic arthritis has on a patient's quality of life. It is a self-administered, 20-item questionnaire that takes about three minutes to complete. The answers are restricted to true or false.A high score on the PsAQoL indicates a lower quality of life. Total score is between 0 and 20.
Study NCT05962034 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: 650 mg aspirin (Acetylsalicylic acid)
Study NCT05962034 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo capsule
Study NCT05256784 — intervention group
Intervention type: COMBINATION_PRODUCT
Intervention: Natural probiotics
Description: Two of the group members use daily Allium Sativum - garlic, one use Natural honey, and 1 Yogurt. It is verifying the immunity of the organism after 40 days of using natural probitotics.
Study NCT05596487 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: repetitive standardized patient simulation
Description: In the study, an end-of-life care nursing education program was applied to all students. In the second stage, the standard patient-based practice was performed once with the control group nursing students and twice with the intervention group students. In data collection, an end-of-life care nursing questionnaire, Frommelt attitude scale, positive-negative affect scale, and modified simulation effectiveness tool were used.
Study NCT05479435 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Blue Prescription Exercise Program
Description: After the evaluation, DM and physical activity training will be given, the benefits of exercise will be explained and these will be given as a brochure. It will be followed up with the blue prescription program once a week for 12 weeks and will be re-evaluated at the end of the 12th week. Motivation and support will be provided according to the blue prescription philosophy, home exercise program, physical activity selection, obstacles to the activity are discussed, the participant will be asked to determine the appropriate program and keep an activity diary. Throughout the study, the participant will be able to communicate with the physiotherapist by any method (phone, SMS, email).
Study NCT05479435 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Video Based Home Exercise Program
Description: After the evaluation, DM and physical activity training will be given, the benefits of exercise will be explained and these will be given as a brochure. A video exercise program will be given in the format and method desired by the participant. It will be evaluated again at the end of the 12th week.
Study NCT05479435 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Supervised Group Exercise Program
Description: DM and physical activity training will be given after the assessment, the benefits of the exercise will be explained and these will be given as a brochure. Exercises will be done with a physiotherapist for 12 weeks 3 days a week and will be evaluated again at the end of the 12th week.
Study NCT05000268 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Progressive Myofascial Relaxation Exercise
Description: Participants will be given telerehabilitation methods, progressive myofascial relaxation techniques and simple posture correction exercises every other day for 2 weeks. The exercises will be performed as follows:~* First, focus on creating tension in the body by contracting all your body muscles and feeling the body tension by holding this tight position for 3-5 seconds. Then relax and relax and focus on feeling the relaxed position of the muscles for 10-15 seconds. Then, the same contraction and relaxation movements will be applied in the feet, legs, hips, waist, chest, shoulders, arms and face areas, respectively. They will be asked to do these exercises in the morning and evening while lying in bed.
Study NCT05357924 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: robotic-assisted laparoscopy
Description: Superficial and deep endometriosis resection will be performed in the usual standard fashion. All superficial lesions suspicious for endometriosis (pigmented and nonpigmented) will be completely resected until non-diseased peritoneal margins are visualized around the defect; all deep lesions suspicious for endometriosis will be completely resected until non-diseased margins are visualized in the tissue surrounding the defect. Cystectomy will be performed for endometriomas. Additional procedures are performed as needed to completely resect all endometriosis lesions. The fascia of any port ≥10 mm will be reapproximated. Cystoscopy will be performed when deemed appropriate by the surgeon. If bowel resection and re-anastomosis is necessary this will be performed together with a General Surgeon.
Study NCT05357924 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional laparoscopy
Description: Superficial and deep endometriosis resection will be performed in the usual standard fashion. All superficial lesions suspicious for endometriosis (pigmented and nonpigmented) will be completely resected until non-diseased peritoneal margins are visualized around the defect; all deep lesions suspicious for endometriosis will be completely resected until non-diseased margins are visualized in the tissue surrounding the defect. Cystectomy will be performed for endometriomas. Additional procedures are performed as needed to completely resect all endometriosis lesions. The fascia of any port ≥10 mm will be reapproximated. Cystoscopy will be performed when deemed appropriate by the surgeon. If bowel resection and re-anastomosis is necessary this will be performed together with a General Surgeon.
Study NCT05724654 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Skin roasted peanuts
Description: Study volunteers will receive daily 60 g of skin roasted peanuts for 16 weeks.
Study NCT05844592 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: INV-101
Description: subjects will be randomized 3:1 ratio
Study NCT04974203 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AptameX
Description: DNA aptamer-based test using patient's saliva
Study NCT06200922 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic physiotherapy
Description: All groups will receive the same treatment for 12 weeks, which will include floor muscle training pelvic floor, urge suppression techniques, bladder training and behavioral therapy.
Study NCT06200922 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pelvic physiotherapy
Description: All groups will receive the same treatment for 12 weeks, which will include floor muscle training pelvic floor, urge suppression techniques, bladder training and behavioral therapy.
Study NCT06312566 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: brivaracetam (BRV) tablet
Description: Study participants will receive multiple-doses of brivaracetam tablet (reference - Treatment A) administered orally.
Study NCT06312566 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: brivaracetam (BRV) dry syrup
Description: Study participants will receive multiple-doses of brivaracetam dry syrup (test - Treatment B) administered orally.
Study NCT04693169 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 11C-Choline
Description: 1、PSMA137 labeled with \[Al18F\] will be used as a molecular imaging tracer for PET/CT scanning。 2、11C-choline (0.05-0.1mCi/kg) was injected intravenously in a week after the \[Al18F\]PSMA137 PET/CT examination, and imaging of the head and body cadres was performed 20 min after the injection using Philips Gemini TF16 or Siemens Biograph M-CT flow PET/CT
Study NCT05383989 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: UniVenture Hopelessness manual
Description: Intended for those who score at least 0.5 standard deviation (SD) above the population-specific norm on Hopelessness (HOP) personality traits on the Substance Use Risk Profile Scale (SURPS).
Study NCT05383989 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: UniVenture Hopelessness manual
Description: Intended for those who score at least 0.5 standard deviation (SD) above the population-specific norm on Hopelessness (HOP) personality traits on the Substance Use Risk Profile Scale (SURPS).
Study NCT04785625 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Bupivacaine Hydrochloride
Description: INL-001 (bupivacaine hydrochloride) implant
Study NCT04785625 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo collagen-matrix implant
Description: Placebo collagen-matrix implant
Study NCT04646005 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Administered intravenously (IV) every three weeks (Q3W)
Study NCT05383989 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: UniVenture Anxiety Sensitivity manual
Description: Intended for those who score at least 0.5 standard deviation (SD) above the population-specific norm on Anxiety Sensitivity (AS) personality traits on the Substance Use Risk Profile Scale (SURPS).
Study NCT05383989 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: UniVenture Anxiety Sensitivity manual
Description: Intended for those who score at least 0.5 standard deviation (SD) above the population-specific norm on Anxiety Sensitivity (AS) personality traits on the Substance Use Risk Profile Scale (SURPS).
Study NCT04646005 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ISA101b
Description: Administered by subcutaneous (SC) injection on day 1, day 29, and day 50
Study NCT05383989 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: UniVenture Sensation Seeking manual
Description: Intended for those who score at least 0.5 standard deviation (SD) above the population-specific norm on Sensation Seeking (SS) personality traits on the Substance Use Risk Profile Scale (SURPS)